In 1996, using combinatorial chemistry and valine pyrrolidide as a starting point DPP-728 was discovered (3); only 3 years later DPP-728 provided the first proof of concept that a DPP-4 inhibitor improves glycemia in patients with T2DM (6). The gene discussed is DPP4; the disease is type 2 diabetes mellitus.